I thought the deal Pharmaxis did today was interesting...http://www.copyright link/business/...50m-beohringer-ingelheim-deal-20150518-gh45b1
$39m up-front based on interim data that has not yet gone through clinical trials. Doesn't sound too far away from where PYC want to be by year-end, i.e. getting into the clinic with a few internal projects.
Might solve a few cash flow concerns if they could pull something like that through..
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.25 |
Change
-0.055(4.23%) |
Mkt cap ! $726.1M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.26 | $1.24 | $173.1K | 139.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 33352 | $1.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 7691 | 1 |
View Market Depth
| Last trade - 16.10pm 07/08/2025 (20 minute delay) ? |
| PYC (ASX) Chart |